The Cancer Outreach Program (COP) is as a service intended to educate and mobilize communities to take action to prevent and control cancer. A goal is to increase the number of people who are in racial/ethnic minorities who are screened for cancer. The common, unifying theme for the Partnership is to deploy Community Health Advisors (CHAs) to provide cancer-related health promotion and cancer education to the public. The MSM COP continues to train CHAs, who participate in the colorectal cancer screening intervention program, Educational Program to Increased Colorectal Cancer Screening (EPICS), which is designed to increase screening among African-Americans. In building a statewide CHA networl<, MSM helped to construct the Breast Health Connection of Georgia, which uses CHAs to promote breast cancer screening, and partnered with the Fulton County Department of Health (FCDH) in the use of CHAs in promotion of colorectal cancer screening. In the recent past, four Legacy Grants were awarded to community organizations. One community-based participatory research (CBPR) project involves an HPV vaccine another is related to prostate cancer. There is a CBPR course for students enrolled in clinical research at MSM. In the next funding period, MSM will further develop its colorectal cancer screening initiative as a dissemination research project, using CHAs as instructors and health promoters.

Public Health Relevance

Increased screening for cancer enhances the liklihood that cancers will be detected at early stages, at which they are more responsible to treatment. More extensive screening of minorities should reduce the cancer disparities between groups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118638-07
Application #
8555489
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y (O1))
Project Start
2005-09-29
Project End
2016-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
7
Fiscal Year
2012
Total Cost
$283,165
Indirect Cost
$83,049
Name
Morehouse School of Medicine
Department
Type
DUNS #
102005451
City
Atlanta
State
GA
Country
United States
Zip Code
30310
Piyathilake, Chandrika J; Badiga, Suguna; Borak, Samuel G et al. (2017) A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome. Int J Womens Health 9:413-420
Williams, Samuel K; Braxton, Joanne M; Gosdin, Melissa et al. (2017) Evidence-Based Care for the Elderly: Uses of ""the Grandmother Principle"". J Health Care Poor Underserved 28:7
Ojeaga, Ashley; Alema-Mensah, Ernest; Rivers, Desiree et al. (2017) Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA. J Cancer Educ :
Stewart, Tarianna; Koval, William T; Molina, Samuel A et al. (2017) Calibrated flux measurements reveal a nanostructure-stimulated transcytotic pathway. Exp Cell Res 355:153-161
Tchio Mantho, Cynthia I; Harbuzariu, Adriana; Gonzalez-Perez, Ruben R (2017) Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer. World J Clin Oncol 8:178-189
Harmon, Tia; Harbuzariu, Adriana; Lanier, Viola et al. (2017) Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer. World J Clin Oncol 8:54-66
Joffe, Ari R; Bara, Meredith; Anton, Natalie et al. (2016) The ethics of animal research: a survey of the public and scientists in North America. BMC Med Ethics 17:17
Peng, Yin; Song, Lanying; Li, Ding et al. (2016) Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in mice. Cardiovasc Res 112:532-542
Xu, J; Footman, A; Qin, Y et al. (2016) BRCA1 Mutation Leads to Deregulated Ubc9 Levels which Triggers Proliferation and Migration of Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells. Int J Chronic Dis Ther 2:31-38
Zhang, Wei; Yi, Bin; Wang, Chao et al. (2016) Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells. Clin Cancer Res 22:2545-54

Showing the most recent 10 out of 95 publications